Transcatheter heart valves technologies

Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J‐TVT

Published on 07/04/2022 | Tsuyoshi Kaneko MD 1 et al. | Journal of the American Heart Association 2022; 11(6): 023848 | 25 minute read

Abstract Background The practice pattern and outcome of medical devices following their regulatory approval may differ by country. The aim

Transcatheter heart valves technologies

One‐year results following PASCAL‐based or MitraClip‐based mitral valve transcatheter edge‐to‐edge repair

Published on 21/03/2022 | Nicolas A. Geis 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.13849 | 25 minute read

Abstract Aims Mitral valve transcatheter edge‐to‐edge repair (TEER) has been established as a suitable alternative to mitral valve surgery in

Transcatheter heart valves technologies

Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database

Published on 21/03/2022 | Ayman ElbadawiMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30072 | 16 minute read

Abstract Background There is a paucity of data regarding the sex‐related differences in the trends and outcomes of trans‐septal transcatheter

Transcatheter heart valves technologies

TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States

Published on 10/03/2022 | Timothy F. SimpsonMD et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30134 | 9 minute read

Abstract Objectives To evaluate transcatheter aortic valve replacement (TAVR) operator procedural volumes, and describe temporal and geographic trends.Background TAVR is

Transcatheter heart valves technologies

Peripheral access size evaluation in transfemoral transcatheter aortic valve replacement

Published on 24/02/2022 | Irbaz HameedMD 1 et al. | Journal of Cardiac Surgery 2022; AOP: 10.1111/jocs.16293 | 16 minute read

Abstract Background/Aim Peripheral access vessel dimensions in the general patient population screened for transcatheter aortic valve replacement (TAVR) can offer

Transcatheter heart valves technologies

Current and future transcatheter aortic valve replacement valves

Published on 24/02/2022 | Eikelboom et al. | Current Opinion in Cardiology 2022; 37(2): 173-9 | 15 minute read

Abstract Purpose of review This review analyzes currently available commercial transcatheter aortic valve replacement (TAVR) valves as well as valves

Transcatheter heart valves technologies

Temporal Trends and Drivers of Heart Team Utilization in Transcatheter Aortic Valve Replacement: A Population‐Based Study in Ontario, Canada

Published on 10/02/2022 | Gil Marcus MD 1 et al. | Journal of the American Heart Association 2021; 10(13): 020741 | 18 minute read

Abstract Background The multidisciplinary Heart Team (HT) is recommended for management decisions for transcatheter aortic valve replacement (TAVR) candidates, and

Transcatheter heart valves technologies

Muscle fat index is associated with frailty and length of hospital stay following transcatheter aortic valve replacement in high-risk patients

Published on 27/01/2022 | Heidari et al. | International Journal of Cardiology 2022; 348(1 February 2022): 33-8 | 0 minute read

Transcatheter heart valves technologies

The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification

Published on 27/01/2022 | Hector R. CajigasMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30057 | 16 minute read

Abstract Objectives To assess the impact of pulmonary hypertension (PH) on outcomes of patients with severe mitral annular calcification (MAC)

Transcatheter heart valves technologies

Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?

Published on 20/01/2022 | GiulioRusso @giuliorus 1 et al. | European Journal of Heart Failure 2021; AOP: 10.1002/ejhf.2398 | 41 minute read

Abstract Tricuspid regurgitation (TR) is a highly prevalent valvular heart disease and is associated with an increased risk of cardiovascular

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.